Revisions of 'Tubulinopathy'
-
Revision 10 - created 5 months ago by Arlene Campos - view changesetDate: 2023-11-16 00:27:29 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Dalia Ibrahim -
Revision 9 - created 5 months ago by Dalia Ibrahim - view changesetDate: 2023-11-14 20:00:12 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Andrea Molinari -
Revision 8 - created 7 months ago by Ryan Thibodeau - view changesetDate: 2023-10-06 03:38:15 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Joachim Feger -
Revision 7 - created 7 months ago by Arlene Campos - view changesetDate: 2023-09-25 01:52:47 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Ryan Thibodeau -
Revision 6 - created 7 months ago by Dalia Ibrahim - view changesetDate: 2023-09-24 06:56:54 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Pir Abdul Ahad Aziz Qureshi -
Revision 5 - created 7 months ago by Dalia Ibrahim - view changesetDate: 2023-09-22 07:47:52 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no financial relationships to ineligible companies to disclose.
View Dalia Ibrahim's current disclosures Reviewed by: Yusra Sheikh -
Revision 4 - created 9 months ago by Mostafa Elfeky - view changesetDate: 2023-07-24 09:42:38 UTC Disclosures:
At the time the revision was created Mostafa Elfeky had no financial relationships to ineligible companies to disclose.
View Mostafa Elfeky's current disclosures Reviewed by: Pir Abdul Ahad Aziz Qureshi -
Revision 3 - created almost 2 years ago by Frank Gaillard - view changesetDate: 2022-06-14 23:02:30 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Mohamed Saber -
Revision 2 - created almost 2 years ago by Dalia Ibrahim - view changesetDate: 2022-06-12 17:11:19 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no recorded disclosures.
View Dalia Ibrahim's current disclosures Reviewed by: Ryan Thibodeau -
Revision 1 - created almost 2 years ago by Dalia Ibrahim - view changesetDate: 2022-06-12 15:28:27 UTC Disclosures:
At the time the revision was created Dalia Ibrahim had no recorded disclosures.
View Dalia Ibrahim's current disclosures Reviewed by: Frank Gaillard
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.